University of Pennsylvania

ScholarlyCommons
Issue Briefs

Leonard Davis Institute of Health Economics

9-7-2011

Behavioral Economics and Health Annual Symposium
Janet Weiner
University of Pennsylvania, weinerja@mail.med.upenn.edu

David A. Asch
University of Pennsylvania, asch@wharton.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/ldi_issuebriefs
Part of the Behavioral Economics Commons, and the Health Communication Commons

Weiner, Janet and Asch, David A.. Behavioral Economics and Health Annual Symposium. LDI Issue Briefs.
2011; 17 (1). http://ldi.upenn.edu/policy/issue-briefs/2011/09/07/behavioral-economics-and-healthannual-symposium

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/ldi_issuebriefs/95
For more information, please contact repository@pobox.upenn.edu.

Behavioral Economics and Health Annual Symposium
Abstract
The application of behavioral economics to health and health care has captured the imagination of
policymakers across the political spectrum. The idea is that many people are irrational in predictable
ways, and that this both contributes to unhealthy behaviors like smoking and holds one of the keys to
changing those behaviors. Because health care costs continue to increase, and a substantial portion of
costs are incurred because of unhealthy behaviors, employers and insurers have great interest in using
financial incentives to change behaviors. However, it is in the details that complexity and controversies
emerge. Who should the targets be, and what outcomes should be rewarded? How should incentives be
structured, to maximize their effectiveness and minimize unintended consequences? In what situations
should we be intervening to affect decisions by people who may prefer to be obese or to smoke, and in
what situations should we accept their preferences?
To begin to answer these questions, the Penn-CMU Roybal P30 Center on Behavioral Economics and
Health held its first annual Behavioral Economics and Health Symposium on March 24-25, 2011 with
support from the Robert Wood Johnson Foundation. The symposium drew more than 50 researchers,
scholars, and health professionals from a variety of disciplines, including medicine, public health,
economics, law, management, marketing, and psychology. They heard perspectives on behavioral
economics from public and private funders, the CEO of the University of Pennsylvania Health System, and
the CEO of stickK.com, a start-up company that uses online, voluntary commitment contracts to help
people achieve their goals. Participants formed eight working groups to review the current state-of-the-art
in a variety of clinical contexts and to consider how behavioral economics could inform a research
agenda to improve health. This Issue Brief summarizes the findings of these working groups and the
symposium.

Keywords
health behavior & communication, behavioral economics/behavior change

Disciplines
Behavioral Economics | Health Communication

License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.

This brief is available at ScholarlyCommons: https://repository.upenn.edu/ldi_issuebriefs/95

Leonard Davis Institute of Health Economics

Volume 17, Issue 1, September 2011

SPECIAL ISSUE:

Behavioral Economics and Health Annual Symposium
Editor’s note: The application of behavioral economics to health and health care has captured the imagination of
policymakers across the political spectrum. The idea is that many people are irrational in predictable ways, and that
this both contributes to unhealthy behaviors like smoking and holds one of the keys to changing those behaviors.
Because health care costs continue to increase, and a substantial portion of costs are incurred because of unhealthy
behaviors, employers and insurers have great interest in using financial incentives to change behaviors. However, it
is in the details that complexity and controversies emerge. Who should the targets be, and what outcomes should
be rewarded? How should incentives be structured, to maximize their effectiveness and minimize unintended
consequences? In what situations should we be intervening to affect decisions by people who may prefer to be obese
or to smoke, and in what situations should we accept their preferences?
To begin to answer these questions, the Penn-CMU Roybal P30 Center on Behavioral Economics and Health held
its first annual Behavioral Economics and Health Symposium on March 24-25, 2011 with support from the Robert
Wood Johnson Foundation. The symposium drew more than 50 researchers, scholars, and health professionals from
a variety of disciplines, including medicine, public health, economics, law, management, marketing, and psychology.
They heard perspectives on behavioral economics from public and private funders, the CEO of the University
of Pennsylvania Health System, and the CEO of stickK.com, a start-up company that uses online, voluntary
commitment contracts to help people achieve their goals. Participants formed eight working groups to review
the current state-of-the-art in a variety of clinical contexts and to consider how behavioral economics could
inform a research agenda to improve health. This Issue Brief summarizes the findings of these working groups and
the symposium.

Setting the stage: introductory remarks by George Lowenstein, PhD, Co-Director of the
Penn-CMU Roybal Center
Dr. Lowenstein balanced enthusiasm for the potential
of behavioral economics to improve health with
concerns about how incentive programs might actually
be used. More than 50% of all large employers are
now incorporating incentives in 2011 health plans.

The 2010 Affordable Care Act will likely spur further
interest, because as of 2014 it allows employers to use
up to 50% of health insurance premiums as incentives
for employees to achieve outcome-based wellness
goals (Section 2705, also known as “The Safeway

Amendment”). How can behavioral economic solutions
augment, rather than supplant, other effective strategies
to improve health, such as new laws or price changes?
He noted that unhealthy behaviors are ubiquitous,
leading to rising obesity rates, deaths from tobacco
and alcohol use, and poor adherence to medications.
These behaviors persist, he said, because they reflect
“internalities,” costs for the individual that are not
recognized in the present and that reflect self-control
problems and inconsistency in preferences over time.

For example, the same individual who wants to lose
weight in the future will often continue to eat too
much and not exercise enough in the present because
the costs of changing those behaviors loom very large
in the present and the benefits are somewhat intangible
and far away in the future. Behavioral economics
recognizes that such inconsistencies are common and
that interventions to be successful must address these
issues. One approach is by substituting immediate,
tangible costs and benefits for internalities.

Behavioral economics: applying what we know
principles to “supercharge” incentives using
common errors in our decisionmaking processes,
as shown below:

Incentive programs have been effective in changing
certain health behaviors, such as substance abuse.
The ongoing challenge is to apply behavioral economic
Decision Error

Potential Response

Present-biased preferences (myopia)
Framing and segregating rewards
Overweighting small probabilities
Regret aversion
Optimism bias
Loss aversion

Make rewards for beneficial behavior frequent and immediate
Reward more likely to be effective than discount on premium
Provide probabilistic rewards, such as a lottery
Tell people they would have won had they sustained beneficial behavior
Encourage pre-commitment and goal setting
Put rewards at risk if behavior doesn’t change

Funders looking for answers
and implementable solutions to some of the most
vexing problems in health, such as obesity, diabetes,
drug abuse, and medication adherence. They urged
behavioral economists to focus on these priorities and
suggested mechanisms for securing funding.

A panel of private and public funders laid out the
pressing problems they were grappling with in their
efforts to improve health and health care. Collectively,
they stressed that they were looking for innovative

Group presentation on health insurance benefit design: simplifying choices
choose (coverage, copays, deductibles, premiums), and
how and when to utilize coverage.
Research in fields other than health provides a basis
for understanding the factors that influence choices at
the health benefit level. From the financial field, for

Employers, employees, and payers are considering
how behavioral economics can inform decisions about
health plan benefits. Decision points occur around
which health plan to choose (through cafeteria plans
or individual health exchanges), which plan features to
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example, we know that complexity can cause delay and
confusion, and default options can have a dramatic
effect on choices. Thus, completion of college financial
aid applications improved with the introduction of a
standardized form and structured options; participation
in 401(k) retirement plans increased greatly by
simplifying the enrollment process and through
changing defaults to make enrollment an opt-out as
opposed to an opt-in.
The group suggested a research agenda that focuses
on the following questions pertaining to health
insurance benefit design:

• Prices: How do people think about prices in the
context of health? When do people respond to price
levers? Do people use price as a signal for quality?
• Psychological aspects of cost-sharing: how do people
respond to low deductibles vs. low copays? Do
people prefer all-inclusive plans to avoid having to
pay at multiple times?
• Complexity: When and how should choices be made
simpler? Is there a role for purposeful complexity?
• Targeting: Where and when do we want to target
interventions (patients, providers, employers,
insurers)? Is payment structure too crude a tool?

Group presentation on provider incentives: targets and teams
Financial incentives targeted to providers (pay-forperformance, or P4P) have been touted as a way for
clinicians, hospitals, and health care systems to improve
the quality of care they deliver. Providers are rewarded
for reaching pre-defined benchmarks and quality
measures. Large health plans, employers and state
Medicaid agencies are now implementing various kinds
of P4P programs.
The group noted that provider incentives have great
potential to affect outcomes, but we lack sufficient
evidence about effective approaches to structuring the
incentives. Rigorous studies of P4P in health care are
few, and overall findings are mixed, even for large
dollar amounts.

Research should focus on:
• Broader outcomes: clinical outcomes beyond
the target outcome; costs; static outcomes versus
dynamic changes in outcomes; process outcomes;
patient satisfaction; trust in provider
• Targets of incentives: individuals vs. teams; how
to define the team, and how to structure team
incentives. Team incentives often turn into
risk-sharing arrangements that may not
improve outcomes.
• Interaction of incentives and social factors, as
incentives are likely to be responsive to context
• Interaction of patient and provider incentives

Group presentation on screening: what do people really want?
incentives have also been effective in increasing HIV
screening rates, although the effects are not linear.
However, HIV screening has not been shown to be
a cost-effective way to reduce transmission of HIV.
Most strategies to increase cancer screening have
been educational (providing information to groups

The group focused on three types of screening:
health risk assessments (HRAs), HIV screening, and
cancer screening. Financial incentives have been
used to increase rates of HRA completion, although
the evidence for whether HRA completion leads to
subsequent changes in behavior is limited. Financial
3

or individuals), and reducing barriers to care by
eliminating copays. Financial incentives to physicians

and whether to use pre-commitment strategies, default
options, and/or financial incentives to change behavior.

have had limited success.
The group noted that important gaps remain in our
basic understanding of people’s motivations around
screening. Knowing people’s reasons for not being
screened may affect whether and how we intervene.
Behavioral economic interventions might best be
targeted, at least initially, to people who want to be
screened but have failed to do so.
The group suggested a research agenda that would
help us more broadly to understand when to intervene,

A fruitful avenue for research lies in systematic
assessment of:
• knowledge and intentions about screening;
• expectations and beliefs about health;
• how expectations and beliefs would change by
screening;
• the comparative effectiveness of pre-commitment
strategies, default options, and/or financial incentives
in changing behavior.

Group presentation on obesity and physical activity: hard to maintain
• What are the right things to reward: weight, body
fat, exercise? How do we measure them accurately in
scalable ways?
• How do we avoid perverse effects, such as purging or
discouraging muscle gain?
• What is the cost effectiveness of a) incentives vs.
other approaches; b) various incentive designs?
• How do we help people form durable habits?
• How much should we worry about extrinsic rewards
crowding out intrinsic motivation?
• How do we tailor interventions to the enrollee?
To what extent should people choose their own
goal? Can people accurately predict what will work
for them?
• What are the health consequences of (e.g.) exercising
for six months, but then relapsing?
• Should financial incentives be paired with other
weight loss/maintenance interventions?

In the face of rising rates of obesity, and despite the
knowledge of the benefits of weight loss, the vast
majority of people fail in attempts to lose weight and
keep it off.
In terms of exercise, studies show that people
overestimate how much they will go to the gym, and
underestimate the value of forming exercise habits.
Behavioral economics may help us design more
effective interventions to increase exercise, improve
diet, and achieve and sustain weight loss. Lotteries and
deposit contracts have been effective in achieving initial
weight loss, but the effects were not sustained. Ongoing
studies are evaluating the effects of combining financial
incentives, group rewards, and peer networks.
The group defined the following areas for
future research:

4

Group presentation on food labeling: changes needed
In response to rising rates of obesity, policymakers have
looked to food labeling to enable and encourage people
to make better food choices. In theory, food labeling
can affect consumer behavior by providing information
to individuals, thereby fostering learning and salience
about nutrition. It might also affect supplier behavior
by having a shaming effect on restaurants, which might
offer more nutritious selections. The 2010 Affordable
Care Act mandates calorie listings on the menu boards
of chain restaurants with 20 or more locations.
But studies show that present labels have not had
much effect on people’s food choices. Behavioral
economics suggests that information alone will not
lead to dietary changes, especially if the information
is complex or consumers lack background knowledge,
such as how many calories they “should” eat.
The group outlined a research agenda that addresses
challenges in making food labels effective, such as:

• Understandability: simplifying food labels; testing
numerical scales; altering the visual presentation
• Personalization: how to make labels more specific to
individual dietary needs
• Balancing single choices and overall diet
• Behavioral factors: Positive vs. negative framing; selfcontrol issues
• Tradeoffs between improvements in health and
incremental cost
• Sources of information: differential responses to
government (mandated labels, required calorie
postings); private firms (Hannaford’s guiding stars,
Whole Foods’ aggregate nutrient density index,
Subway’s low fat), or third parties (Weight Watchers,
mobile apps)

Group presentation on medication adherence: not just about copays
interventions to be able to provide frequent, ongoing
feedback at low cost and at scale. They recommended
a research agenda for applying behavioral economic
methods to medication adherence, including:
• How can we incentivize sustainable behavior change:
what are the optimal dollar amounts for incentives,
and do they vary by socioeconomic status? What
are the spillover effects to other non-incentivized
medications?
• How can we combine incentives for providers
and patients?
• Can we target non-adherents? Can we target people
based on risk for non-adherence?
• Can we use social psychological nudges to
sustain adherence?

Policymakers and employers are looking to Valuebased Insurance Design (VBID) as a way to improve
medication adherence. VBID looks to reduce barriers
to, and promote use of, high-value health care. Because
medication adherence worsens when patients face
increasing copayments, it seems reasonable to assume
that reducing copayments would lead to improved
adherence. However, studies have shown that reducing
copays is relatively ineffective at improving adherence,
possibly because the change in amounts is small, or the
feedback too infrequent. Behavioral economics
can be used to refine VBID programs and improve
medication adherence.
The group noted that investment in information
technology is critical for behavioral economic

5

Group presentation on substance abuse: strategies to abstain, quit and stay quit
strategy be applied to alcohol or illicit drugs? One
idea for monitoring pre-commitments is to enable
smartphone GPS tracking to alert a third party that
an addict has entered a high-risk zone.
• Incentives: Could pre-commitment and incentives
be combined to prevent smoking initiation among
teenagers? One idea is to create abstinence pledge
at schools with a monthly lottery prize for testing
negative for tobacco use. Can monthly lotteries be
sed to prevent delayed relapse among addicts after
the drug treatment phase?
• Substitution: Since drug treatment involves
taking away something pleasurable, can we replace
it with a new pleasurable activity? How can
behavioral economics inform the selection of an
effective substitute?

The field of drug abuse treatment has had the longest
experience with behavioral economic interventions and
continues to experiment with ways to reinforce positive
behaviors and combat relapse.
Work to date has discovered the importance of
excessive discounting of delayed rewards among
substance abusers, and the effectiveness of supplying
alternative reinforcers (such as vouchers) in retaining
people in treatment and encouraging abstinence.
The group focused on three behavioral economic
methods that hold the most promise for substance
abuse treatment. These are:
• Pre-commitment: self-imposed internet and casino
bans are an example of pre-commitment applied
to the treatment of problem gambling. Can this

Group presentation on ethics: are we nannying or nurturing?
tackled at the societal level? For example, should we
pay people to lose weight or rather, subsidize food
producers/farmers to produce healthier food?
• Autonomy vs. effectiveness: In designing
interventions, how do we balance maximizing
effectiveness with preserving individual choice? For
example, in the United States, organ donation is a
matter of simple consent. Some European nations
have implemented presumed consent, in which
someone must opt out of organ donation. Opt-out
strategies increase the rate of consent, at the cost of
some level of autonomy.
• Fairness: When are behavioral economics policy
levers discriminatory? Are incentives equally
effective across targeted individuals? People of
low socioeconomic status may be subject to more
incentives or “nudges.” However, they may also
experience larger health benefits so the net impact
may be favorable. The potential for discrimination is
greater as the targeted behavior is less modifiable.

The ethics group provided a framework for
understanding the rationale for intervening with
behavioral economics. Interventions might be justified
because the externalities imposed (healthy subsidizing
the unhealthy) seem unjust or inefficient; they could
also be justified because the internalities imposed seem
unduly burdensome and prompt a sense of beneficence
toward individuals who can’t help themselves. The
substantive question is: which internalities merit
attention, and who decides?
Even if we can agree on the focus of interventions,
significant ethical issues have arisen, and continue
to arise, as we develop, test, and implement the
interventions. Even a simple strategy of changing
default options can unduly burden the person who
might want to choose otherwise.
The group highlighted the following ethical issues
warranting attention as behavioral economics is applied
to health:
• Level of the intervention: Are we implicitly
burdening individuals with problems that should be
6

Cross-cutting themes and wrap-up
and reminders, or prescription drugs. They also
discussed changing processes through mandates,
defaults, feedback, reminders, commitment devices,
substitution, and aligning incentives.
She concluded that further research should focus
on which methods work best in what situations.
How and when should we use the tools of behavioral
economics to build the “house” – good health – and
given constraints, which tools or set of tools are best
to use?
David Asch, MD, MBA, Executive Director of
the Leonard Davis Institute of Health Economics
at Penn, noted the interest in behavioral economics
from diverse stakeholders. The symposium, he said,
highlighted the considerable number of “known
unknowns” in the field and laid the groundwork
for a persuasive agenda for research and research
funding. Some of the cross-cutting issues in applying
behavioral economics to health are:
• The underuse of recommended care, and how to
address the deficiencies of providers, patients, and
the health care system
• The right structure for incentives, considering
aspects such as size, frame, frequency, duration,
form, and how these aspects interact with their
context
• The right triggers for incentives (whether
process or outcome-based, single items or
multifactorial indices, static thresholds or
improvements from baseline)
• The right ways to evaluate incentives, including
outcomes such as clinical effectiveness, cost
effectiveness, acceptability, spillover, crowd-out
effects, endurance of effect, and changes over time
• The effects on the culture of personal behavior,
social relationships, intrinsic motivation, and
personal responsibility

The symposium ended with three presentations
summarizing the discussions and offering
perspectives on themes that cut across the topics.
Maxine Stitzer, PhD, Professor of Psychiatry and
Behavioral Sciences at Johns Hopkins University,
noted the tendency to look at behaviors individually.
She urged participants to think about the larger
box and consider multiple domains or problems
concurrently. Doing so brings up questions about
which bundles of behaviors can be addressed
together, and in what order. In the realm of
substance abuse, targeting one drug often has a
beneficial effect on other drug use. She also stressed
the importance of social reinforcement and the
development of interventions that transform external
tangible incentives to external social incentives.
Lastly, she questioned where the money for financial
incentives would come from, which is a large issue
when working with community treatment providers.
Brigitte Madrian, PhD, Professor of Public Policy
and Corporate Management at Harvard, discussed
the success of changing the default on retirement
savings plans in changing behavior. Automatic
enrollment worked so well, she said, for two reasons,
first, most people want to save for retirement and
second, automatic enrollment simplifies doing
what most people already want to do. Intervention
becomes more difficult, she noted, when what is
easy and what people want is not the same. There
are unsettled questions about what people want
when it comes to health, and whether we can change
what people want, through information, incentives,
psychological interventions, or social interventions.
Simplifying what people want to do can involve
changing the product or the process. Throughout the
symposium, groups discussed simplifying products,
such as nutrition labels, prescription bottle caps
7

The Penn-CMU Roybal Center on Behavioral Economics and Health began in 2009 with a grant from the National
Institute on Aging. It specializes in research and dissemination strategies that foster the translation of behavioral economic
theory to improve health-promoting behaviors and health care delivery in older adults. It is led by Kevin Volpp, MD, PhD
(University of Pennsylvania) and George Loewenstein, PhD (Carnegie Mellon University). For more information, go to
www.med.upenn.edu/ldichi/
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